44. Canada wishes to address questions raised by South Africa at our 30 July 2020 meeting in relation to Canada's presentation of a COVID-19specific measure, as notified in document IP/N/1/CAN/30. As the TRIPS Council may recall, this notification pertains to recent amendments to Canada's Patent Act under Bill C-13 (an act respecting certain measures in response to COVID-19). Bill C-13 required the Commissioner of Patents, on the application of the Minister of Health, to authorize the Government of Canada or another specified person to make, construct, use and sell a patented invention to the extent necessary to respond to the COVID-19 pandemic. These amendments included safeguards to protect the interests of patent holders, for example, ensuring that a patent holder received adequate remuneration for the making, using, constructing, and selling of the patented invention, placing limitations on the duration of the authorization, and ensuring that the patent owner had recourse to the courts if any person authorized acted outside the scope of the authorization.
45. By way of update, we report that no authorizations have been issued pursuant to this amendment, and the powers to seek authorization for third-party manufacturers were in place until 30 September 2020, as set out in the original 25 March 2020 amendments. Canada wishes to stress that these measures were in addition to, and at no time replaced, existing pathways for the authorization of the use of a patent under Canada's Patent Act, which remain in place under Canada's domestic regime.
46. Canada remains committed to ensuring that its IP system supports efforts to address COVID19. The Canadian Intellectual Property Office (CIPO) has, for example, launched a pilot programme that allows accelerated examination of patent applications at no additional cost for inventions related to medical products and processes supporting the response to COVID-19. As well, ExploreIP: Canada's IP Marketplace, which is a new online resource for businesses to explore licensing and collaboration opportunities with public sector patent holders, now features a new "COVID-19-related" category to help users find technologies that could help combat COVID-19. Canada looks forward to presenting on these IP-related responses to the pandemic in greater detail, under the upcoming agenda item "IP measures in the context of COVID-19", later in this TRIPS Council meeting.